Benlysta (belimumab)
pCPA File Number:
21220
Negotiation Status:
Under consideration for negotiation
Indication(s):
Systemic lupus erythematosus
Sponsor/Manufacturer:
GlaxoSmithKline Inc.
CADTH Project Number:
SR0616
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded:
Not Applicable